Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
about
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsCB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseasePlant derived substances with anti-cancer activity: from folklore to practiceBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemWhat we know and do not know about the cannabinoid receptor 2 (CB2)Endocannabinoid signaling in social functioning: an RDoC perspectiveThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionRegulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infectionCB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.Towards molecular imaging of multiple sclerosis.Global fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulations.Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors.CB2: a cannabinoid receptor with an identity crisisModeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.CB1 receptor autoradiographic characterization of the individual differences in approach and avoidance motivationImpact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage.The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.Evaluation of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitisCannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.New vistas on cannabis use disorder.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsHIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virusThe highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults.Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituents.Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese MiceActivation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsCNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Cannabinoid receptor 2 protects against acute experimental sepsis in mice
P2860
Q24617322-436B3CEE-0E77-425C-9816-93A7772053D4Q26746050-25803F61-F40D-4BF9-8BB6-C39DF8C4B0F6Q26781498-26C480DC-742E-425A-BC73-6325BD165D51Q26865295-E15C91DB-9EC0-40EA-B795-CDF0BE4085B3Q27686851-2077A8B4-D7B2-421E-B598-67AA73A28B21Q28067103-1519A666-9237-4A99-AB92-C0C93A977D7AQ28068881-B6F45C47-459D-4520-9B93-15280D2F1498Q28283718-922CDAFB-930B-4255-95F5-A382DDED999EQ30410119-8CF80C16-D613-4D1F-B366-628294D21DCEQ30470076-3D7C26F4-D1D0-4155-8959-E469F91523D8Q33396602-2ACADBA6-09BC-4092-AAF5-84DC26446BDBQ33605261-EB3E73A8-6E89-4E2C-98D9-1B153EE2185CQ33755702-0816348E-0706-48E6-92FA-50B78F1E6E1BQ33787779-B99300EC-E32F-484F-BCFC-B74C6CF98C6DQ33809669-0CE74147-706A-4ACB-8661-07BE2AF6A6CCQ34089051-D32FB57C-FBA4-4239-A575-85803BB408E4Q34098185-5257A5D8-E7DD-449C-8866-669B97C0D3C5Q34222925-0DD4273C-59F6-4336-B953-FD80516F7015Q34359544-CA5AB24C-F88D-4C04-9BFC-5E053CE5262EQ34486027-9928A851-C0B9-4F86-8596-517C035C1E61Q34496064-C9E076C4-BE53-4F59-99FF-B8B629AB06B3Q34533857-C2BB6313-9308-4F39-99C9-701F901E22BEQ34565750-08F71F2A-8648-4487-ABE0-BB57EB6FFAAEQ34591087-C27E8959-F3AA-4A10-ABEF-B68C97F30373Q34680801-EAD3DAE8-C527-4199-9852-4053078D4081Q34681365-6B0CC02A-DB62-4B96-A492-A5186205E645Q34700334-5CD379F3-830B-4D06-835D-37B185351889Q34993393-25207B68-58A0-46FA-8D57-CFAE351541C2Q35119113-D5FA60F9-EA82-4045-82C8-4666660B8067Q35122796-CAFD89C2-F02C-49DD-81CB-F82F1696FC2FQ35184435-0E98275A-4775-4886-96C4-10942F7712FAQ35587290-0B2630DB-BBC9-43E3-9D58-E730A4FB23EAQ35672413-000D823D-DFA1-464E-AEDE-195D05845D60Q35688511-5B774BE6-2C1C-4FC5-906A-8D874E84D47AQ35763187-F3999B2A-02CD-4244-9FC2-D902F9C88DF5Q35847290-5D5DA6AB-DA96-4AAC-9658-F0F6BCB07A1CQ35887816-B6A8DE75-CEB4-48B1-9A12-CC67AC391E3BQ36071533-E535CFE5-B6A4-4ED9-B4C7-6BF3323AEFE5Q36176444-5E1E252C-9DE8-4FCB-9CC6-FCA69278B5ADQ36921431-66F55CFF-42B6-488A-99B2-A0526BA36236
P2860
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Emerging role of the cannabino ...... rospects for neuroinflammation
@ast
Emerging role of the cannabino ...... rospects for neuroinflammation
@en
Emerging role of the cannabino ...... rospects for neuroinflammation
@nl
type
label
Emerging role of the cannabino ...... rospects for neuroinflammation
@ast
Emerging role of the cannabino ...... rospects for neuroinflammation
@en
Emerging role of the cannabino ...... rospects for neuroinflammation
@nl
prefLabel
Emerging role of the cannabino ...... rospects for neuroinflammation
@ast
Emerging role of the cannabino ...... rospects for neuroinflammation
@en
Emerging role of the cannabino ...... rospects for neuroinflammation
@nl
P2860
P921
P3181
P1476
Emerging role of the cannabino ...... rospects for neuroinflammation
@en
P2093
Guy A Cabral
LaToya Griffin-Thomas
P2860
P3181
P356
10.1017/S1462399409000957
P407
P577
2009-01-01T00:00:00Z